De fleste patienter, der behandles med Zevalin, oplever en kraftig reduktion i antallet af blodceller, der har behov for nogen tid til at normaliseres igen efter behandlingen.
Most patients treated with Zevalin experience a severely reduced number of blood cells, which needs some time to normalise again after treatment.